432 related articles for article (PubMed ID: 29428298)
1. The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice.
Hordeaux J; Wang Q; Katz N; Buza EL; Bell P; Wilson JM
Mol Ther; 2018 Mar; 26(3):664-668. PubMed ID: 29428298
[TBL] [Abstract][Full Text] [Related]
2.
Batista AR; King OD; Reardon CP; Davis C; Shankaracharya ; Philip V; Gray-Edwards H; Aronin N; Lutz C; Landers J; Sena-Esteves M
Hum Gene Ther; 2020 Jan; 31(1-2):90-102. PubMed ID: 31696742
[TBL] [Abstract][Full Text] [Related]
3. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
4. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
[TBL] [Abstract][Full Text] [Related]
5. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
[TBL] [Abstract][Full Text] [Related]
6. Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice.
Davidson CD; Gibson AL; Gu T; Baxter LL; Deverman BE; Beadle K; Incao AA; Rodriguez-Gil JL; Fujiwara H; Jiang X; Chandler RJ; Ory DS; Gradinaru V; Venditti CP; Pavan WJ
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34407999
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy.
Choudhury SR; Fitzpatrick Z; Harris AF; Maitland SA; Ferreira JS; Zhang Y; Ma S; Sharma RB; Gray-Edwards HL; Johnson JA; Johnson AK; Alonso LC; Punzo C; Wagner KR; Maguire CA; Kotin RM; Martin DR; Sena-Esteves M
Mol Ther; 2016 Aug; 24(7):1247-57. PubMed ID: 27117222
[TBL] [Abstract][Full Text] [Related]
8. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
[TBL] [Abstract][Full Text] [Related]
9. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain.
Deverman BE; Pravdo PL; Simpson BP; Kumar SR; Chan KY; Banerjee A; Wu WL; Yang B; Huber N; Pasca SP; Gradinaru V
Nat Biotechnol; 2016 Feb; 34(2):204-9. PubMed ID: 26829320
[TBL] [Abstract][Full Text] [Related]
10. Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier.
Albright BH; Storey CM; Murlidharan G; Castellanos Rivera RM; Berry GE; Madigan VJ; Asokan A
Mol Ther; 2018 Feb; 26(2):510-523. PubMed ID: 29175157
[TBL] [Abstract][Full Text] [Related]
11. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea.
Frederick A; Sullivan J; Liu L; Adamowicz M; Lukason M; Raymer J; Luo Z; Jin X; Rao KN; O'Riordan C
Hum Gene Ther; 2020 Jul; 31(13-14):756-774. PubMed ID: 32578442
[TBL] [Abstract][Full Text] [Related]
12. An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice.
Jin Q; Qiao C; Li J; Li J; Xiao X
Gene Ther; 2020 May; 27(5):237-244. PubMed ID: 31819202
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice.
Xie BS; Wang X; Pan YH; Jiang G; Feng JF; Lin Y
Theranostics; 2021; 11(3):1177-1191. PubMed ID: 33391529
[No Abstract] [Full Text] [Related]
15. Intravenous Infusion of AAV for Widespread Gene Delivery to the Nervous System.
Gessler DJ; Tai PWL; Li J; Gao G
Methods Mol Biol; 2019; 1950():143-163. PubMed ID: 30783972
[TBL] [Abstract][Full Text] [Related]
16. Receptor targeting of adeno-associated virus vectors.
Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
[TBL] [Abstract][Full Text] [Related]
17. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids.
Huang Q; Chan KY; Tobey IG; Chan YA; Poterba T; Boutros CL; Balazs AB; Daneman R; Bloom JM; Seed C; Deverman BE
PLoS One; 2019; 14(11):e0225206. PubMed ID: 31725765
[TBL] [Abstract][Full Text] [Related]
18. Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration.
Chai Z; Zhang X; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2018 Sep; 286():415-424. PubMed ID: 30107215
[TBL] [Abstract][Full Text] [Related]
19. Systemic gene transfer to skeletal muscle using reengineered AAV vectors.
Phillips JL; Hegge J; Wolff JA; Samulski RJ; Asokan A
Methods Mol Biol; 2011; 709():141-51. PubMed ID: 21194026
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Selection of a Computationally Designed SCHEMA AAV Library Yields a Novel Variant for Infection of Adult Neural Stem Cells in the SVZ.
Ojala DS; Sun S; Santiago-Ortiz JL; Shapiro MG; Romero PA; Schaffer DV
Mol Ther; 2018 Jan; 26(1):304-319. PubMed ID: 28988711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]